Frequently Asked Questions
The global ECoa eSource and clinical trials market was valued at USD 45.7 Billion in 2022.
The ECoa eSource and clinical trials market is expected to grow at a CAGR of 8.30% between 2023 and 2030, reaching USD 79.8 Billion in 2030.
The pharmaceutical and biotechnology firms category accounts for approximately 55% of the eCOA eSource and clinical trials market in 2022.
Contract research organizations (CROs) account for a sizable portion of the demand for eCOA eSource and clinical trials technologies.
The electronic clinical outcome assessment (eCOA) category is predicted to grow at the fastest rate in the eCOA eSource and clinical trials market.
Asia Pacific is fueling the growth of the ECoa eSource and clinical trials industry, with over one-third share in 2022.
The top players include Medidata Solutions, Medable, OpenClinica and ArisGlobal LLC. Other major players include Covance, ERT Clinical, Parezel International Corporation and Health Diary.
Mobile Health Technology Adoption is Growing, as is the Use of eClinical Technologies in Clinical Trials are the major market drivers.
Issues with Data Security and Regulatory Difficulties are the major market restraints.
Expansion of Personalized Medicine and Patient Monitoring via the Internet are the major opportunities in the ECoa eSource and clinical trials industry.